ReviewDer Orthopade2015
[Total hip arthroplasty in overweight osteoarthritis patients].
Review in Der Orthopade, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- [Personality and comorbidity: are there "difficult patients" in hip arthroplasty?].Der Orthopade · 2015Pooled it
- [Analysis of rising treatment cost of elevated BMI in patients with proximal femoral fracture].Unfallchirurgie (Heidelberg, Germany) · 2023Article
- [Hip dysplasia: What influence do age, arthrosis and concomitant diseases have on the treatment result?]Orthopadie (Heidelberg, Germany) · 2023Review
- Femoral Stress Changes after Total Hip Arthroplasty with the Ribbed Prosthesis: A Finite Element Analysis.BioMed research international · 2020Article
- The Application of MSCs-Derived Extracellular Vesicles in Bone Disorders: Novel Cell-Free Therapeutic Strategy.Frontiers in cell and developmental biology · 2020Review
- Exosomes and Stem Cells in Degenerative Disease Diagnosis and Therapy.Cell transplantation · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAn increasing number of patients scheduled for total hip arthroplasty (THA) are obese and exhibit a different risk profile from that of patients of normal weight.
objectivesTo provide an overview of the impact of obesity on the outcome of primary THA. MATERIALS AND
methodsLiterature review and discussion of own epidemiological data.
resultsObese patients can expect as much functional improvement as non-obese patients after THA. However, peri- and postoperative complication (e.g., periprosthetic infection and dislocation) rates are reported to be increased in obese THA patients.
conclusionsThe knowledge of obesity-associated risks is the prerequiste for successful THA in obese patients.
Indexed as
Identifiers
25894514What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.